Literature DB >> 15716123

Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells.

Martin Vejrazka1, Radan Mícek, Stanislav Stípek.   

Abstract

Apocynin is a naturally occurring methoxy-substituted catechol, experimentally used as an inhibitor of NADPH oxidase. Since it acts as a potent inhibitor in studies with neutrophils and macrophages, no inhibitory effect can often be found in non-phagocyte cells. In our experiments, apocynin even stimulated reactive oxygen species (ROS) production by vascular fibroblasts. Even when added to macrophages, apocynin initially caused an increase in ROS production. The inhibition of ROS formation followed, suggesting that in the presence of leukocyte myeloperoxidase and hydrogen peroxide, apocynin is converted to another compound. Apocynin pre-activated with H2O2 and horseradish peroxidase (HRP) inhibited ROS production immediately. In non-phagocytes, apocynin stimulated ROS production and no inhibition was observed even after 60 min. Apocynin treated with H2O2 and HRP, however, decreased ROS production in the same manner as in macrophages. The stimulatory effect on ROS production can be abolished by tiron and superoxide dismutase (SOD), suggesting that superoxide was the produced species. The effect of apocynin was inhibited by diphenylene iodinium (DPI), a non-scavenging NADPH oxidase inhibitor. It can be summarized that apocynin stimulates cell superoxide production. In the presence of peroxidase and hydrogen peroxide, however, it is converted into another compound that acts as an inhibitor of superoxide production. It strongly suggests that under conditions in vivo, apocynin can have opposite effects on phagocytes and non-phagocyte cells. It acts as an inhibitor of phagocyte NADPH oxidase but also as a ROS production stimulator in non-phagocyte cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15716123     DOI: 10.1016/j.bbagen.2004.12.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  64 in total

Review 1.  NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.

Authors:  Hui-Ming Gao; Hui Zhou; Jau-Shyong Hong
Journal:  Trends Pharmacol Sci       Date:  2012-04-11       Impact factor: 14.819

2.  A simple magnetic separation method for high-yield isolation of pure primary microglia.

Authors:  Richard Gordon; Colleen E Hogan; Matthew L Neal; Vellareddy Anantharam; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  J Neurosci Methods       Date:  2010-11-11       Impact factor: 2.390

Review 3.  NADPH oxidase in stroke and cerebrovascular disease.

Authors:  Xian Nan Tang; Belinda Cairns; Jong Youl Kim; Midori A Yenari
Journal:  Neurol Res       Date:  2012-05       Impact factor: 2.448

4.  Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress.

Authors:  Sathish Kumar Natarajan; Donald F Becker
Journal:  Cell Health Cytoskelet       Date:  2012-02-01

5.  A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids.

Authors:  Sangderk Lee; Nima M Gharavi; Henry Honda; Irene Chang; Brandon Kim; Nelson Jen; Rongsong Li; Alejandro Zimman; Judith A Berliner
Journal:  Free Radic Biol Med       Date:  2009-04-16       Impact factor: 7.376

Review 6.  NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?

Authors:  Joanna Wieczfinska; Milena Sokolowska; Rafal Pawliczak
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 7.  New insights on NOX enzymes in the central nervous system.

Authors:  Zeynab Nayernia; Vincent Jaquet; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2014-01-16       Impact factor: 8.401

8.  Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes.

Authors:  Elyara M Soares; Katie L Mason; Lisa M Rogers; Carlos H Serezani; Lucia H Faccioli; David M Aronoff
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

9.  Resveratrol inhibits foam cell formation via NADPH oxidase 1- mediated reactive oxygen species and monocyte chemotactic protein-1.

Authors:  Dae Weon Park; Kheewoong Baek; Jae Ryong Kim; Jae Jin Lee; Sang Ho Ryu; Byung Rho Chin; Suk Hwan Baek
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

Review 10.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.